Expertise in
1
conditions

Alexandre Khuskivadze

Tbilisi, TB, GE 
Expertise in
1
conditions
Tbilisi, TB, GE 

Overview

Alexandre Khuskivadze practices practicing medicine in Tbilisi, Georgia.

Mr. Khuskivadze is highly rated in 1 condition, according to our data. His clinical expertise encompasses Non-Muscle Invasive Bladder Cancer, Bladder Cancer, and Urothelial Cancer.

He is actively involved in clinical research, co-authoring 8 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Tbilisi, TB, Georgia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of UGN-102 as Primary Chemoablative Therapy in Patients With Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC) at Intermediate Risk (IR) of Recurrence
A Phase 3, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of UGN-102 as Primary Chemoablative Therapy in Patients With Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC) at Intermediate Risk (IR) of Recurrence
Enrollment Status: Active_not_recruiting
Publish Date: May 11, 2026
Intervention Type: Drug
Study Drug: UGN-102
Study Phase: Phase 3
A Randomized, Controlled, Open-Label Study of the Efficacy, Durability, and Safety of UGN-102 With or Without TURBT in Patients With Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)
A Randomized, Controlled, Open-Label Study of the Efficacy, Durability, and Safety of UGN-102 With or Without TURBT in Patients With Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)
Enrollment Status: Terminated
Publish Date: June 06, 2024
Intervention Type: Drug, Procedure
Study Drug: Mitomycin C
Study Phase: Phase 3
View 1 Less Clinical Trial

8 Total Publications

UTILIZING INFRARED IMAGING TO EVALUATE THE AGGRESSIVENESS OF PROSTATE CANCER.
UTILIZING INFRARED IMAGING TO EVALUATE THE AGGRESSIVENESS OF PROSTATE CANCER.
Journal: Experimental oncology
Published: December 30, 2025

Frequently Asked Questions about Alexandre Khuskivadze

Is Alexandre Khuskivadze a top-rated expert for Non-Muscle Invasive Bladder Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Alexandre Khuskivadze is classified as an Advanced expert for Non-Muscle Invasive Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Alexandre Khuskivadze participate in research or clinical trials?

Yes. Alexandre Khuskivadze has published 8 articles and abstracts on conditions like Non-Muscle Invasive Bladder Cancer. You can view a list of Alexandre Khuskivadze's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Khuskivadze's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile